ReviewClinical advances in hematology & oncology : H&O2017

Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease.

Steven S Yu et al.PubMed ↗Full text ↗

No numbers read from the abstract.